HIV Self-Testing in India: Moving from Evidence to Action

India recorded more than 1.7 million new cases of HIV in the last 10 years between 2011 and 2021. To attain India's commitment to achieve the United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets by 2030 and end the AIDS epidemic as a public health threat by 2030 in line with Sustainable Development Goals, India needs to strengthen the prevention-testing-treatment-care continuum.

Leveraging the experience of STAR phases 1 and 2, PATH has been implementing the STAR Phase 3 project in India. The implementation study was conducted to demonstrate the feasibility and acceptability of HIVST across specific populations. The study was conducted in 14 high HIV prevalence states of India through five service delivery models. A detailed analysis plan was developed to examine and review the findings from the study. As the study concluded in June 2022, the process of data analysis was conducted to understand the information collected from the study participants.

PATH has developed high-quality, reliable, and ready-reference knowledge products like the summary report and a compendium of success stories on various interventions, lessons learnt and key takeaways of the HIV Self Testing project in India.

Publication date: October 2022

Available materials

  1. English

    1. Accelerating access and uptake of HIV Self-Testing in India - A demonstration project 1.3 MB PDF

      This document summarizes the various interventions, lessons learnt, and key takeaways of the HIV Self-Testing project in India.

  2. English

    1. A Compendium of success stories of overcoming barriers to HIV Self-Testing in India

      This compendium of success stories traces how HIV Self-Testing (HIVST) has helped different individuals from different walks of life in being able to test themselves for the virus and get linked to treatment services. The cases are from Nagaland, Chennai, and West Bengal and revolve around migrant laborers, injecting drug users, and persons living with HIV.